NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10411	Companies
217811	Keywords
147360	Articles
115249	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 10/11/2024 at 22:15, 1 year 7 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Nanobiotix publie mensuellement le nombre total d'actions et de droits de vote. La société de biotechnologie développe des traitements innovants. Pour plus d'informations, visitez www.nanobiotix.com

Droits De Vote Biotechnologie Actions Traitements NANOBIOTIX
PRESS RELEASE

published on 09/18/2024 at 22:42, 1 year 7 months ago

Rapport Financier Semestriel 2024
BRIEF

published on 09/18/2024 at 22:20, 1 year 7 months ago

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results

Revenue Increase Clinical Milestones Nanobiotix Financials NBTXR3 Progress Cash And Runway
BRIEF

published on 09/18/2024 at 22:20, 1 year 7 months ago

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers du premier semestre 2024

Augmentation Des Revenus Résultats Financiers De Nanobiotix Progression De NBTXR3 Étapes Cliniques Marquantes De L'argent Et De La Piste
PRESS RELEASE

published on 09/18/2024 at 22:15, 1 year 7 months ago

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
Nanobiotix updates on operational progress and reports Half Year 2024 financial results, showcasing clinical milestones and licensing agreements with Janssen. Cash reserves extended until Q4 2025

Financial Results Clinical Milestones NANOBIOTIX Half Year 2024 Janssen Agreement
PRESS RELEASE

published on 09/18/2024 at 22:15, 1 year 7 months ago

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2024
Nanobiotix publie ses résultats financiers et présente les avancées de NBTXR3, une approche innovante en oncologie basée sur les nanoparticules. Nouvelles collaborations et perspectives de développement clinique

Résultats Financiers Oncologie NANOBIOTIX NBTXR3 Nanoparticules
BRIEF

published on 09/04/2024 at 22:20, 1 year 8 months ago

NANOBIOTIX Enhances Supervisory Board with Two Key Additions

Biotechnology Supervisory Board NANOBIOTIX Dr. Liu Anat Naschitz
BRIEF

published on 09/04/2024 at 22:20, 1 year 8 months ago

NANOBIOTIX renforce son Conseil de Surveillance avec deux ajouts clés

Biotechnologie Conseil De Surveillance NANOBIOTIX Dr Liu Anat Nachitz
PRESS RELEASE

published on 09/04/2024 at 22:15, 1 year 8 months ago

NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
Nanobiotix announces key additions to Supervisory Board - Dr. Margaret A. Liu & Ms. Anat Naschitz. Expertise to drive growth in nanophysics-based therapies for cancer & major diseases

Supervisory Board NANOBIOTIX Dr. Margaret A. Liu Ms. Anat Naschitz Nanophysics-based Therapies
BRIEF

published on 09/03/2024 at 22:20, 1 year 8 months ago

Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference

Biotechnology Webcast Fireside Chat NANOBIOTIX Investment Conference

Accesswire

Published on 05/16/2026 at 01:15, 8 hours 8 minutes ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 8 hours 23 minutes ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 9 hours 23 minutes ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 10 hours 13 minutes ago

Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 10 hours 23 minutes ago

Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency

View all ACCESSWIRE

EQS Group

Published on 05/15/2026 at 20:10, 13 hours 13 minutes ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 14 hours 53 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:30, 14 hours 53 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 15 hours 13 minutes ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 15 hours 50 minutes ago

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio

Les Echos

Published on 05/15/2026 at 15:08, 18 hours 15 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 18 hours 23 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 23 hours 13 minutes ago

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 15 hours ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

View all LES ECHOS COMFI WIRE